Trial Profile
Phase III study of SUN11031 for eating disorders
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Ghrelin (Primary)
- Indications Anorexia nervosa; Eating disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 24 May 2016 New trial record